24Oct 2023
Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs

Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs

A recent study highlights the impact of topical antihypertensive (TAH) drugs on glaucoma patients' ocular health. The research involved 154 eyes, 77 receiving TAH drugs and 77 in a control group. The study found that the TAH drug group experienced higher tear film osmolarity and meibomian gland loss while having lower noninvasive break-up time, lipid layer thickness, and tear meniscus height. These patients also had a significantly higher global OSDI score and a greater proportion of severe disease and dry eye symptoms. Corneal fluorescein staining was more common in the TAH group. The study underscores the multifactorial nature of dry eye disease in glaucoma patients, with TAH drugs exacerbating ocular surface issues and dry eye symptoms. Clinicians should be aware of these effects.

  • #ophthalmology

Like

Save

Share